Intensive blood pressure treatment does not improve cardiovascular outcomes in centrally obese hypertensive individuals with diabetes: The Action to Control Cardiovascular Risk in Diabetes (ACCORD) blood pressure trial

Diabetes Care

Volumn 35, Issue 7, 2012, Pages 1401-1405

  Barzilay, Joshua I ^a   Howard, Annie G ^b   Evans, Gregory W ^b   Fleg, Jerome L ^c   Cohen, Robert M ^d   Booth, Gillian L ^e   Kimel, Angela R ^f   Pedley, Carolyn F ^b   Cushman, William C ^g  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^d UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY OF TORONTO   (Canada)

^f WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

^g VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FENOFIBRATE; PLACEBO; SIMVASTATIN;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE REGULATION; BODY HEIGHT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RESPONSE; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE CONTROL; FEMALE; FOLLOW UP; HEART DEATH; HEART INFARCTION; HUMAN; HYPERTENSION; INTENSIVE CARE; MAJOR CLINICAL STUDY; MALE; OBESITY; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; STROKE; TREATMENT OUTCOME; WAIST CIRCUMFERENCE;

BLOOD PRESSURE; BODY HEIGHT; CARDIOVASCULAR DISEASES; COHORT STUDIES; DIABETES COMPLICATIONS; DIABETES MELLITUS; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; OBESITY; PROPORTIONAL HAZARDS MODELS; RISK; STROKE; WAIST CIRCUMFERENCE;

EID: 84862860566     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc11-1827     Document Type: Article

References (16)

1. Canoy D, Luben R, Welch A, et al. Fat distribution, body mass index and blood pressure in 22,090 men and women in the Norfolk cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC-Norfolk) study. J Hypertens 2004;22:2067-2074 (Pubitemid 39463798)
2. Wofford MR, Hall JE. Pathophysiology and treatment of obesity hypertension. Curr Pharm Des 2004;10:3621-3637 (Pubitemid 39386578)
3. Tuomilehto J, Rastenyte D, Birkenhäger WH, et al. Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension.Systolic Hypertension in Europe Trial Investigators. N Engl J Med 1999;340:677-684 (Pubitemid 29110751)
4. ACCORD Study Group; Cushman WC, Evans GW, Byington RP, et al. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl JMed 2010;362:1575-1585
5. Buse JB, Bigger JT, Byington RP, et al.; ACCORD Study Group. Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: design and methods. Am J Cardiol 2007;99(Suppl.):21i-33i
6. Gerstein HC, Miller ME, Byington RP, et al.; Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008;358:2545-2559 (Pubitemid 351831356)
7. Cushman WC, Grimm RH Jr, Cutler JA, et al.; ACCORD Study Group. Rationale and design for the blood pressure intervention of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Am J Cardiol 2007;99(Suppl.):44i-55i
8. Browning LM, Hsieh SD, Ashwell M. A systematic review of waist-to-height ratio as a screening tool for the prediction of cardiovascular disease and diabetes: 0.5 could be a suitable global boundary value. Nutr Res Rev 2010;23:247-269
9. Sacco RL, Adams R, Albers G, et al.; American Heart Association/American Stroke Association Council on Stroke; Council on Cardiovascular Radiology and Intervention; American Academy of Neurology. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals fromthe American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Circulation 2006;113:e409-e449 (Pubitemid 43739468)
10. Sluik D, Boeing H, Montonen J, et al. Associations between general and abdominal adiposity and mortality in individuals with diabetes mellitus. Am J Epidemiol 2011;174:22-34
11. Yusuf S, Hawken S, Ounpuu S, et al.; INTERHEART Study Investigators. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet 2005;366:1640-1649 (Pubitemid 41552419)
12. Czernichow S, Kengne AP, Huxley RR, et al.; ADVANCE Collaborative Group. Comparison of waist-to-hip ratio and other obesity indices as predictors of cardiovascular disease risk in people with type-2 diabetes: a prospective cohort study from ADVANCE. Eur J Cardiovasc Prev Rehabil 2011;18:312-319
13. Tseng CH. Waist-to-height ratio and coronary artery disease in Taiwanese type 2 diabetic patients.Obesity (Silver Spring) 2008;16:2754-2759
14. Sone H, Tanaka S, Iimuro S, et al. Waist circumference as a cardiovascular and metabolic risk in Japanese patients with type 2 diabetes. Obesity (Silver Spring) 2009;17:585-592
15. Sarwar N, Gao P, Seshasai SR, et al Emerging Risk Factors Collaboration. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet 2010;375:2215-2222
16. Sattar N, Murray HM, Welsh P, et al.; Prospective Study of Pravastatin in the Elderly at Risk (PROSPER) Study Group. Aremarkers of inflammationmore strongly associated with risk for fatal than for nonfatal vascular events? PLoS Med 2009;6:e1000099